The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
The Epidemiology of Sepsis in the United States from 1979 through 2000
Open accessAbstract
BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This approach follows the methods validated by many studies on the epidemiology of sepsis26, 27, 28, 29 and was used by Rudd and colleagues.10”
From Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024) · cites this paper as [28]
In the citing paper
“This trend continued with a greater than 200% increase from 1979 to 2000.23”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [23]
In the citing paper
“McNeil et al. (154) published an analysis of trends in infectious disease mortality in the United States and found a dramatic increase in multiple-cause mortality due to mycoses, from 1,557 deaths in 1980 to 6,534 deaths in 1997; the majority of these mycoses-related deaths were associated with Candida , Aspergillus , and Cryptococcus sp. infection.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“At the same time, they showed an almost exponential increase in the mortality rates associated with IA, with a 357% increase in mortality between 1980 and 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Previously, McNeil et al. (154) demonstrated that mortality rates associated with IC increased steadily from 1980 to a peak in 1989, followed by a gradual decline through 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“These data are directly comparable to those of McNeil et al. (154) and extend the data reported in that study beyond 1996 to the year 2003.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Again, the limitations of such data are well known, most notably the lack of validation of the mycotic infection and the failure to clinically diagnose IA and IC, resulting in an underestimation of mortality (154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“As stated by McNeil and colleagues (154), mortality associated with invasive mycoses is best represented by multiplecause-of-death data, which capture any mention of the mycotic disease on the death certificate.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Although this approach provides a much more generalizable sample of U.S. hospitals than many other methods of surveillance, it is likely to underestimate both incidence and mortality because of miscoding of IC, use of codes not captured by the analysis, or failure to code the infection at all (79, 154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Rising Incidence of Hepatocellular Carcinoma in the United States
El‐Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,865
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., & Wenzel, R. P. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,090
High-Dose Antithrombin III in Severe Sepsis
Warren, B., Eid, A. A., Singer, P., Pillay, S., Carl, P., Novák, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,422
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.274.12.968 · Cited by 1,079
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- 1990, MMWR Morb Mortal Wkly Rep, 39, 31
- Eaton S, 2002, Am J Respir Crit Care Med, 165, A471
Cited by
Sorted by citations
Items 401–500 of 1,032
Novosad, S. A., Sapiano, M. R. P., Grigg, C., Lake, J., Robyn, M., Dumyati, G., Felsen, C., Blog, D., Dufort, E., Zansky, S., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533e1 · Cited by 144
Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines
Tsantes, A. G., Parastatidou, S., Tsantes, E. A., Bonova, E., Tsante, K. A., Mantzios, P. G., Vaiopoulos, G., Tsalas, S., Konstantinidi, A., Houhoula, D. P., et al. (2023) · Life · doi:10.3390/life13020350 · Cited by 185
Multidrug-Resistant Sepsis: A Critical Healthcare Challenge
Kumar, N. R., Balraj, T. A., Kempegowda, S. N., & Prashant, A. (2024) · Antibiotics · doi:10.3390/antibiotics13010046 · Cited by 187
Jacob, S. T., Moore, C. C., Banura, P., Pinkerton, R., Meya, D. B., Opendi, P., Reynolds, S. J., Kenya‐Mugisha, N., Mayanja‐Kizza, H., Scheld, W. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007782 · Cited by 179
Mitochondrial Biogenesis Restores Oxidative Metabolism during Staphylococcus aureus Sepsis
Haden, D. W., Suliman, H. B., Carraway, M. S., Welty‐Wolf, K. E., Ali, A. S., Shitara, H., Yonekawa, H., & Piantadosi, C. A. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-161oc · Cited by 179
The critically ill older patient with sepsis: a narrative review
Ibarz, M., Haas, L. E. M., Ceccato, A., & Artigas, A. (2024) · Annals of Intensive Care · doi:10.1186/s13613-023-01233-7 · Cited by 201
Sha, T., Sunamoto, M., Kitazaki, T., Sato, J., Ii, M., & Iizawa, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.027 · Cited by 177
The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis
LEIPER, J. M., & Nandi, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3358 · Cited by 181
Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia
Eber, M. R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.509 · Cited by 176
The Importance of Toll-Like Receptor 2 Polymorphisms in Severe Infections
Texereau, J., Chiche, J., Taylor, W., Choukroun, G., Comba, B., & Mira, J. P. (2005) · Clinical Infectious Diseases · doi:10.1086/431990 · Cited by 183
Girard, B., Chung, C., O’Brien, X. M., Chen, Y., Reichner, J. S., & Ayala, A. (2016) · Journal of Innate Immunity · doi:10.1159/000448808 · Cited by 176
Parental Dietary Fat Intake Alters Offspring Microbiome and Immunity
Myles, I. A., Fontecilla, N. M., Janelsins, B., Vithayathil, P. J., Segre, J. A., & Datta, S. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301057 · Cited by 177
Gender differences in mortality in patients with severe sepsis or septic shock
Pietropaoli, A. P., Glance, L. G., Oakes, D., & Fisher, S. G. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.09.005 · Cited by 174
The Systemic Pro-Inflammatory Response in Sepsis
de Jong, H. K., van der Poll, T., & Wiersinga, W. J. (2010) · Journal of Innate Immunity · doi:10.1159/000316286 · Cited by 179
Wynn, J. L., Scumpia, P. O., Winfield, R. D., Delano, M. J., Kelly‐Scumpia, K. M., Barker, T. T., Ungaro, R. F., Levy, O., & Moldawer, L. L. (2008) · Blood · doi:10.1182/blood-2008-01-130500 · Cited by 177
Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis
Turgeon, A. F., Hutton, B., Fergusson, D. A., McIntyre, L., Tinmouth, A. A., Cameron, D. W., & Hébert, P. C. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-3-200702060-00009 · Cited by 173
Leveraging electronic health records for data science: common pitfalls and how to avoid them
Sauer, C. M., Chen, L.-C., Hyland, S. L., Girbes, A. R. J., Elbers, P., & Celi, L. A. (2022) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00154-6 · Cited by 183
Boarding of critically ill patients in the emergency department.
Mohr, N. M., Wessman, B. T., Bassin, B., Elie-Turenne, M.-C., Ellender, T., Emlet, L. L., Ginsberg, Z., Gunnerson, K., Jones, K. M., Kram, B., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004385 · Cited by 172
Knowledge gaps in control of Campylobacter for prevention of campylobacteriosis
Hansson, I., Sandberg, M., Habib, I., Lowman, R., & Engvall, E. O. (2018) · Transboundary and Emerging Diseases · doi:10.1111/tbed.12870 · Cited by 172
Vincent, J., & Abraham, E. H. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1604oe · Cited by 173
Epidemiology of Intensive Care Admissions for Children in the US From 2001 to 2019
Killien, E. Y., Keller, M. R., Watson, R. S., & Hartman, M. E. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2023.0184 · Cited by 171
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases
Skevaki, C. L., Pararas, M. V., Kostelidou, K., Tsakris, A., & Routsias, J. G. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12578 · Cited by 174
Frequency, Cost, and Risk Factors of Readmissions Among Severe Sepsis Survivors*
Goodwin, A. J., IV, Rice, D. A., Simpson, K. N., & Ford, D. W. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000859 · Cited by 170
Rhee, C., Murphy, M. V., Li, L., Platt, R. G., & Klompas, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu750 · Cited by 170
The Changing Face of Fungal Infections in Health Care Settings
Weinstein, R. A., & Fridkin, S. K. (2005) · Clinical Infectious Diseases · doi:10.1086/497138 · Cited by 170
Response to trauma and metabolic changes: posttraumatic metabolism
Şimşek, T., Şimşek, H. U., & Cantürk, N. Z. (2014) · Turkish Journal of Surgery · doi:10.5152/ucd.2014.2653 · Cited by 170
Janz, D. R., Bastarache, J. A., Peterson, J. F., Sills, G., Wickersham, N., May, A. K., Roberts, L. J., & Ware, L. B. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182741a54 · Cited by 169
Maternal Sepsis Mortality and Morbidity During Hospitalization for Delivery
Bauer, M. E. B., Bateman, B. T., Bauer, S., Shanks, A. M., & Mhyre, J. M. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182a009c3 · Cited by 169
Tektonidou, M. G., Wang, Z., Dasgupta, A., & Ward, M. M. (2015) · Arthritis Care & Research · doi:10.1002/acr.22575 · Cited by 171
Alcayaga‐Miranda, F., Cuenca, J., Martin, A., Contreras, L., Figueroa, F. E., & Khoury, M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0192-0 · Cited by 168
Rasmussen, R. V., Høst, U., Arpi, M., Hassager, C., Johansen, H. K., Korup, E., Schønheyder, H. C., Berning, J., Gill, S. U. A., Rosenvinge, F. S., et al. (2011) · European Journal of Echocardiography · doi:10.1093/ejechocard/jer023 · Cited by 168
Sepsis-related mortality in China: a descriptive analysis
Weng, L., Zeng, X., Yin, P., Wang, L., Wang, C.-Y., Jiang, W., Zhou, M., & Du, B. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5203-z · Cited by 168
Nakamori, Y., Park, E. J., & Shimaoka, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624279 · Cited by 176
qSOFA does not replace SIRS in the definition of sepsis
Vincent, J., Martin, G. S., & Levy, M. M. (2016) · Critical Care · doi:10.1186/s13054-016-1389-z · Cited by 167
Self-citationHealthcare Disparities in Critical Illness
Soto, G. J., Martin, G. S., & Gong, M. N. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182a84a43 · Cited by 166
Self-citationAcute kidney injury: changing lexicography, definitions, and epidemiology
Himmelfarb, J., & Ikizler, T. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002224 · Cited by 167
Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?
Rhee, C., & Klompas, M. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.51 · Cited by 166
Population-based burden of bloodstream infections in Finland
Skogberg, K., Lyytikäinen, O., Ollgren, J. P., Nuorti, J. P., & Ruutu, P. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03845.x · Cited by 165
Bloos, F., & Reinhart, K. (2013) · Virulence · doi:10.4161/viru.27393 · Cited by 170
Current challenges in the management of invasive fungal infections
Lai, C., Tan, C., Huang, Y., Shao, P., & Hsueh, P. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-007-0595-7 · Cited by 167
Baillot, R. G., Cloutier, D. J., Montalin, L., Cote, L. M., Lellouche, F., Houde, C., Gaudreau, G., & Voisine, P. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.09.023 · Cited by 165
Sepsis Induces Early Alterations in Innate Immunity That Impact Mortality to Secondary Infection
Delano, M. J., Thayer, T. C., Gabrilovich, S., Kelly‐Scumpia, K. M., Winfield, R. D., Scumpia, P. O., Cuenca, A. G., Warner, E., Wallet, S. M., Wallet, M. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002104 · Cited by 165
Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)
Levi, M. M., Levy, M. M., Williams, M. D., Douglas, I. S., Artigas, A., Antonelli, M. M., Wyncoll, D. L. A., Janes, J., Booth, F. V. M., Wang, D., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1803oc · Cited by 165
Horiguchi, H., Loftus, T. J., Hawkins, R. B., Raymond, S. L., Stortz, J. A., Hollen, M. K., Weiss, B. P., Miller, E. S., Bihorac, A., Larson, S. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00595 · Cited by 164
Severe Sepsis and Septic Shock in Pregnancy
Barton, J. R., & Sibai, B. M. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318263a52d · Cited by 165
Sligl, W., Milner, D. A., Sundar, S., Mphatswe, W., & Majumdar, S. R. (2009) · Clinical Infectious Diseases · doi:10.1086/599343 · Cited by 166
Atg7 Deficiency Intensifies Inflammasome Activation and Pyroptosis in Pseudomonas Sepsis
Pu, Q., Gan, C., Li, R., Li, Y., Tan, S., Li, X., Wei, Y., Lan, L., Deng, X., Liang, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601196 · Cited by 164
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
Peri, F., & Piazza, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.05.014 · Cited by 164
Epidemiology of sepsis in Victoria, Australia
Sundararajan, V., MacIsaac, C., Presneill, J., Cade, J. F., & Visvanathan, K. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000150027.98160.80 · Cited by 162
Coagulation in Patients with Severe Sepsis
Levi, M. M., & van der Poll, T. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1398376 · Cited by 165
Timing of vasopressor initiation and mortality in septic shock: a cohort study
Beck, V., Chateau, D., Bryson, G. L., Pisipati, A., Zanotti, S., Parrillo, J. E., Kumar, A., & The Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group (2014) · Critical Care · doi:10.1186/cc13868 · Cited by 161
Chu, X., Di, C., Chang, P., Li, L., Feng, Z., Xiao, S., Yan, X., Xu, X., Li, H., Qi, R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.786666 · Cited by 162
Benfield, T., Espersen, F., Møller, J. K., Jensen, A. G., Larsen, A. R., Pallesen, L., Skov, R. L., Westh, H., & Skinhøj, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01589.x · Cited by 160
Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury
Noiri, E., Doi, K., Negishi, K., Tanaka, T., Hamasaki, Y., Fujita, T., Portilla, D., & Sugaya, T. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90513.2008 · Cited by 160
Doumith, M., Day, M. J., Ciesielczuk, H., Hope, R., Underwood, A. P., Reynolds, R., Wain, J. R., Livermore, D. M., & Woodford, N. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02562-14 · Cited by 160
Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome
Schmidt, E. P., Overdier, K. H., Sun, X., Lin, L., Liu, X., Yang, Y., Ammons, L. A., Hiller, T. D., Suflita, M., Yu, Y., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2281oc · Cited by 160
Fatores de risco associados ao agravamento de sepse em pacientes em Unidade de Terapia Intensiva
Barros, L., Maia, C. D. S. F., & Monteiro, M. C. (2016) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x201600040091 · Cited by 160
Statin use and mortality within 180 days after bacteremia: A population-based cohort study*
Thomsen, R. W., Hundborg, H. H., Johnsen, S. P., Pedersen, L. H., Sørensen, H. T., Schønheyder, H. C., & Lervang, H.-H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000207345.92928.e4 · Cited by 160
Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US)
Bernard, G. R., Margolis, B. D., Shanies, H. M., Ely, E. W., Wheeler, A. P., Levy, H. A., Wong, K. Y., & Wright, T. J. (2004) · CHEST Journal · doi:10.1378/chest.125.6.2206 · Cited by 160
Grant, W. B., Cross, H. S., Garland, C. F., Gorham, E. D., Moan, J. E., Peterlik, M., Porojnicu, A. C., Reichrath, J., & Zittermann, A. (2009) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2009.02.003 · Cited by 162
Qiu, X., Lei, Y., & Zhou, R. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2237192 · Cited by 166
Tsoyi, K., Jang, H. J., Nizamutdinova, I. T., Kim, Y. M., Lee, Y. S., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01126.x · Cited by 158
Therapeutic Intervention and Targets for Sepsis
Rice, T. W., & Bernard, G. R. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104356 · Cited by 159
Epidemiology of Sepsis: Race, Sex, and Chronic Alcohol Abuse
Moss, M. (2005) · Clinical Infectious Diseases · doi:10.1086/432003 · Cited by 157
Self-citationLeelahavanichkul, A., Huang, Y. G., Hu, X., Zhou, H., Tsuji, T., Chen, R., Kopp, J. B., Schnermann, J. B., Yuen, P. S. T., & Star, R. A. (2011) · Kidney International · doi:10.1038/ki.2011.261 · Cited by 157
Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever
Hensley, L. E., Stevens, E. L., Yan, S.-C. B., Geisbert, J. B., Macias, W. L., Larsen, T., Daddario-DiCaprio, K. M., Cassell, G. H., Jahrling, P. B., & Geisbert, T. W. (2007) · The Journal of Infectious Diseases · doi:10.1086/520598 · Cited by 157
Use of mass spectrometry to identify clinical Fusarium isolates
Marinach, C., Lethuillier, A., Marly, A., Brossas, J., Gené, J., Symoens, F., Datry, A., Guarro, J., Mazier, D., & Hennequin, C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02758.x · Cited by 157
Page, D. B., Donnelly, J. P., & Wang, H. E. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001164 · Cited by 157
Whittaker, S.-A., Mikkelsen, M. E., Gaieski, D. F., Koshy, S., Kean, C., & Fuchs, B. D. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827466f1 · Cited by 156
Bench-to-bedside review: β-Adrenergic modulation in sepsis
de Montmollin, É., Aboab, J., Mansart, A., & Annane, D. (2009) · Critical Care · doi:10.1186/cc8026 · Cited by 164
Cauwels, A. (2007) · Kidney International · doi:10.1038/sj.ki.5002340 · Cited by 156
McPherson, D., Griffiths, C., Williams, M. J., Baker, A., Klodawski, E., Jacobson, B., & Donaldson, L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002586 · Cited by 155
Sepsis in Old Age: Review of Human and Animal Studies
Starr, M. E. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500126 · Cited by 157
Staphylococcus aureus bacteremia in patients with prosthetic devices: Costs and outcomes
Chu, V. H. Y., Crosslin, D. R., Friedman, J. Y., Reed, S. D., Cabell, C. H., Griffiths, R. I., Masselink, L. E., Kaye, K. S., Corey, G. R., Reller, L. B., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.011 · Cited by 154
Systemic Steroids in Severe Sepsis and Septic Shock
Patel, G. P., & BALK, R. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1897ci · Cited by 154
Gebhardt, C., Hirschberger, J., Rau, S., Arndt, G., Krainer, K., Schweigert�, F. J., Brunnberg, L., Kaspers, B., & Kohn, B. (2009) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2009.00462.x · Cited by 154
de Oliveira, F. S. V., Freitas, F. G. R., Ferreira, E. M., de Castro, I., Bafi, A. T., Azevedo, L. C. P., & Machado, F. R. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.09.002 · Cited by 154
Ferry, T., Thomas, D., Genestier, A., Bes, M., Lina, G., Vandenesch, F., & Étienne, J. (2005) · Clinical Infectious Diseases · doi:10.1086/432798 · Cited by 153
Stępień, K. M., Heaton, R. A., Rankin, S., Murphy, A., Bentley, J., Sexton, D. W., & Hargreaves, I. P. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070071 · Cited by 153
Wang, W., & Liu, C. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-023-00689-8 · Cited by 161
Chu, V. H. Y., Cabell, C. H., Abrutyn, E., Corey, G. R., Hoen, B., Miró, J. M., Olaison, L., Stryjewski, M. E., Pappas, P. A., Anstrom, K. J., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/424878 · Cited by 153
Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strainsPreprint
Salipante, S. J., Roach, D. J., Kitzman, J. O., Snyder, M. W., Stackhouse, B., Butler‐Wu, S. M., Lee, C., Cookson, B. T., & Shendure, J. (2014) · Genome Research · doi:10.1101/gr.180190.114 · Cited by 158
Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review
Xing, K. H., Murthy, S., Liles, W. C., & Singh, J. M. (2012) · Critical Care · doi:10.1186/cc11145 · Cited by 156
Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis
Armstrong, L., Medford, A. R. L., Hunter, K., Uppington, K. M., & Millar, A. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02433.x · Cited by 152
STAT1 plays a role in TLR signal transduction and inflammatory responses
Luu, K., Greenhill, C. J., Majoros, A., Decker, T., Jenkins, B. J., & Mansell, A. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2014.51 · Cited by 151
Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis
Riedel, S. F. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.002 · Cited by 154
Marino, R., Struck, J., Maisel, A. S., Magrini, L., Bergmann, A., & Somma, S. D. (2014) · Critical Care · doi:10.1186/cc13731 · Cited by 155
Luo, Y., Jiang, L., Kang, K., Fei, D., Meng, X., Nan, C., Pan, S., Zhao, M., & Zhao, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.017 · Cited by 151
Ohlsson, P., Evander, M., Petersson, K., Mellhammar, L., Lehmusvuori, A., Karhunen, U., Soikkeli, M., Seppä, T., Tuunainen, E., Spangar, A., et al. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00323 · Cited by 151
Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis*
Knoell, D. L., JULIAN, M. W., Bao, S., Besecker, B. Y., Macre, J. E., Leikauf, G. D., DiSilvestro, R. A., & Crouser, E. D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819cefe4 · Cited by 150
Furian, T. Q., Aguiar, C., Prado, K. F., Ribeiro, R. V. P., Becker, L. Q., Martinelli, N. C., Clausell, N., Rohde, L. E. P., & Biolo, A. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.06.017 · Cited by 150
Sepsis mortality prediction based on predisposition, infection and response
Moreno, R. P., Metnitz, B., Adler, L., Höchtl, A., Bauer, P., Metnitz, P., & SAPS 3 Investigators (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0943-1 · Cited by 150
HDL in sepsis – risk factor and therapeutic approach
Morin, E. E., Guo, L., Schwendeman, A. A., & Li, X. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00244 · Cited by 153
Sarkar, A., Hall, M. W., Exline, M. C., Hart, J., Knatz, N. L., Gatson, N. T., & Wewers, M. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-546oc · Cited by 150
Hata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149
Pena, O. M., Hancock, D. G., Lyle, N. H., Linder, A., Russell, J. A., Xia, J., Fjell, C. D., Boyd, J. H., & Hancock, R. E. W. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.10.003 · Cited by 153
Sakr, Y. L., Lobo, S. M., Moreno, R. P., Gerlach, H., Ranieri, V. M., Michalopoulos, A. S., Vincent, J., & the SOAP Investigators (2012) · Critical Care · doi:10.1186/cc11868 · Cited by 149
Moriez, R., Salvador–Cartier, C., Théodorou, V., Fioramonti, J., Eutamène, H., & Bueno, L. P. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61196-0 · Cited by 149
Trends in Sepsis and Infection Sources in the United States. A Population-Based Study
Walkey, A. J., Lagu, T. C., & Lindenauer, P. K. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201411-498bc · Cited by 149
Jolley, R., Quan, H., Jetté, N., Sawka, K. J., Diep, L., Goliath, J., Roberts, D. J., Yipp, B. G., & Doig, C. J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009487 · Cited by 153
Metadata
- Authors
- Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M.
- Affiliations
- Emory University (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-17
- Volume
- 348
- Issue
- 16
- Pages
- 1546-1554
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145577370
- Cited by
- 5,841
- References
- 48
- Citations by year
- 2026: 67 · 2025: 128 · 2024: 149 · 2023: 168 · 2022: 167 · 2021: 253 · 2020: 231 · 2019: 211 · 2018: 226 · 2017: 329 · 2016: 292 · 2015: 341 · 2014: 381 · 2013: 436 · 2012: 365
- FWCI
- 123.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA R01-11660, R01AA011660)
- National Heart, Lung, and Blood Institute (K23HL067739, HL K23-67739)
- National Center for Research Resources (L30 RR020488)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- PSIS, sepsis incidence, sepsis mortality, temporal trends, racial disparities, sex differences, Gram-positive bacteria, fungal infection, sepsis pathogens, organ failure, length of hospital stay, hospital discharge disposition, Black men, hospital discharge data, acute care hospitals, healthcare burden
- MeSH terms
- Female, Humans, Male, Middle Aged, Multiple Organ Failure, Sex Factors, United States, Incidence, Survival Rate, Hospital Mortality, Sepsis, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
